Abstract : This article is a comment on: Endurance, aerobic high-intensity, and
repeated sprint cycling performance is unaffected by normobaric “Live
High-Train Low”: a double-blind placebo-controlled cross-over study,
by Bejder J, Andersen AB, Buchardt R, Larsson TH, Olsen NV,
Nordsborg NB. Eur J Appl Physiol (2017) 117:979–988.
